COMMD6 and giant cell tumor: In addition, the methylation status of COMMD6 was highest in lymphocyte malignancies, and lowest in soft tissue cancer, osteosarcoma, leukaemia, giant cell tumour, Ewing’s sarcoma and oesophagus cancer cell lines (Fig. S2C).